Dr. Navjeet Kaur is an early-career veterinary pharmacologist with specialized training in Veterinary Pharmacology & Toxicology, preclinical pharmacology, antimicrobial PK/PD and computational drug discovery. She is currently serving as Scientist Trainee at Anthem Biosciences Limited, Bengaluru (September 2026–Present), where she is engaged in pharmaceutical and biopharmaceutical research and development workflows aligned with industry best practices.

Dr. Kaur holds a Master of Veterinary Science (M.V.Sc.) in Veterinary Pharmacology & Toxicology from Guru Angad Dev Veterinary and Animal Sciences University (GADVASU), Ludhiana (2024–2026) and a Bachelor of Veterinary Science and Animal Husbandry (B.V.Sc. & A.H.) from Sher-e-Kashmir University of Agricultural Sciences and Technology of Jammu (2018–2024). Her postgraduate research examined the disposition of piperacillin–tazobactam in buffaloes undergoing diaphragmatic hernia surgery, including concentration–time profiling, pharmacokinetic parameter interpretation and MIC-linked %T>MIC assessment. Previously, she completed internships and training positions at Roche (July–September 2025), BioTechTrek (May–July 2026), BioPractify (June–July 2026), Pharmoinformatics Lab (September 2026–Present), Springwell Pharma Private Limited (June 2026–Present) and Researium Labs (August–October 2026), acquiring hands-on experience in drug discovery, preclinical development, molecular docking, virtual screening, ADMET analysis, formulation development, quality assurance and pharmaceutical R&D principles.

Research & Publications

Dr. Kaur has developed a research profile spanning preclinical pharmacology, antimicrobial resistance, computational drug discovery and AI-enabled drug development. Her published and submitted work includes three publications and manuscripts under review: a study on piperacillin–tazobactam disposition in buffaloes (published in Toxicology International); a multi-omics systems pharmacology investigation on anaesthesia-dependent antimicrobial resistance adaptation and β-lactam disposition during diaphragmatic herniorrhaphy in buffaloes (submitted to Springer Nature); an article on artificial intelligence and environmental DNA in wildlife conservation and biodiversity monitoring (published in Bio Vet Innovator Magazine); and a contribution on wavefront shaping applications (published in IOSR Journal of Mathematics).

Research Projects & Innovation

Dr. Kaur has designed and conceptualized multiple research and innovation projects demonstrating multidisciplinary competency across computational pharmacology, antimicrobial resistance and artificial intelligence:

• AMR-GraphAgent-X (TigerGraph Agentic GraphRAG Hackathon, September–October 2026): An evidence-driven agentic GraphRAG concept for investigating antimicrobial-resistance questions through knowledge graphs, vector retrieval, multi-hop reasoning, contradiction detection and provenance tracking.
• PHARMA-TWIN X (FutureTech HackFest 2026, August 2026): A computational precision-pharmacotherapy concept combining mechanistic PK/PD, Bayesian updating, Monte Carlo simulation, target-attainment analysis, explainable AI and uncertainty quantification.
• AMR-GUARD X (ML Bubble 2026, August 2026): An machine-learning architecture for antimicrobial-resistance forecasting and hotspot intelligence using temporal and graph-learning approaches, explainability and uncertainty assessment.
• VERISYNTH AI (Decodep, HackDay 1.0, September 2026): An evidence-grounded generative-AI framework with retrieval-augmented generation, claim–evidence linking, contradiction detection and confidence scoring.
• SENTINEL-X (TECHhelp4U, Black-Box Protocol, August–September 2026): An AI-augmented pharmacovigilance system integrating signal detection, natural language processing, temporal analytics and traceable evidence workflows.
• PolymerMind-X (IIT Madras, Amalgam 2026, September 2026): An explainable, uncertainty-aware graph-learning framework for polymer property prediction from molecular representations and physicochemical descriptors.

Technical Expertise & Professional Development

Dr. Kaur possesses comprehensive technical competencies spanning in vivo pharmacology, drug disposition analysis, HPLC/RP-HPLC, LC–MS/MS, computer-aided drug design, molecular docking, virtual screening, QSAR, ADMET analysis, molecular dynamics, bioinformatics and cheminformatics. She has completed specialized training in computer-aided drug design, network pharmacology, bioinformatics and computational molecular biology, LC–MS/MS techniques, pharmaceutical R&D, quality assurance/quality control, quantum technologies, RNA-Seq analysis, deep learning and generative artificial intelligence. Her technical proficiency extends to data analysis and artificial intelligence tools including Excel, SPSS, GraphPad Prism, Python, R, knowledge graphs, explainable AI and uncertainty quantification. She is well-versed in regulatory and quality frameworks including GLP, GMP/cGMP, ICH concepts, MedDRA and pharmacovigilance protocols.

Awards, Honours & Professional Memberships

Dr. Kaur has received recognition for her academic excellence and research contributions, including Certificates of Excellence in Reviewing from the Uttar Pradesh Journal of Zoology and Asian Journal of Biology (September 2026), Certificates of Merit from the International Conference on Engineering and Technology (ICET 2026) and ICAMC 2026, a Certificate of Merit from Vetfest 2023, and a University Merit Scholarship. She serves as a peer reviewer for the Asian Journal of Biology and Uttar Pradesh Journal of Zoology and holds Lifetime Membership in the Indian Society of Veterinary Pharmacology & Toxicology (ISVPT).

Academic & Professional Engagement

Dr. Kaur is actively engaged in academic and professional outreach. She has presented her research at peer-reviewed conferences, including a research poster presentation at VIBCON 2026 on AI-driven, resistance-aware structure-based drug repurposing against multidrug-resistant veterinary pathogens, and a research presentation at IConPharmBioHealth 2026. She has participated in ICVAHS-2026 and ISSAR 2024. Currently, she serves as Ambassador for WildlifeBuzz (August 2026–Present), engaging across wildlife, veterinary, conservation, biodiversity and One Health communities, and as College Ambassador for Techfest, IIT Bombay (2026–27), supporting student engagement and stakeholder outreach.

Eligibility for Laureate Research Award

Dr. Navjeet Kaur demonstrates substantial research productivity and innovation across preclinical pharmacology, antimicrobial resistance and computational drug discovery. Her research combines rigorous experimental methodology with evidence-grounded artificial intelligence, generating publications, conceptualized innovation projects and peer-reviewed presentations. Her technical depth spans analytical chemistry, pharmacokinetics, computational biology and regulatory science, supported by focused professional development across multiple domains. Her engagement as a peer reviewer, professional member and academic ambassador reflects her commitment to scientific rigor and knowledge dissemination within the veterinary and pharmaceutical research communities.

Dr. Navjeet Kaur is eligible for consideration for the Laureate Research Award in Scientific Laurels, in recognition of her contributions to preclinical pharmacology, computational drug discovery, antimicrobial resistance research and translational science.